Innovations for the Management of Cancer, Cardiovascular, and Neurological Diseases

Innovations for the Management of Cancer, Cardiovascular, and Neurological Diseases

RELEASE DATE
13-Sep-2019
REGION
Global
Research Code: D759-00-0C-00-00
SKU: HC03216-GL-TA_23597

$950.00

Special Price $712.50 save 25 %

In stock
SKU
HC03216-GL-TA_23597

$950.00

$712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) captures insights across recent advances in life science, health & wellness. Key advances across liquid biopsy and cancer management have been included. The TOE also analyzes exciting device and therapeutic innovations for the management of neurodegenerative and cardiovascular disorders. Furthermore, the TOE examines recent advances across digital and artificial intelligence-based platforms for healthcare.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Liquid biopsy, cancer, artificial intelligence, drug design, digital health, cochlear, GN Hearing, hearing aid, Android Streaming, blood draw, HbA1C, neuromodulation, neurodegeneration, drug discovery, neuroscience, synapse, genomics, biomarkers, neuroscience, non-invasive therapy, venous disease, aneurysm, sepsis, ADHD, upper-limb neuromuscular disorder, CorInnova, heart failure, robotic, ARTIDIS, biopsy, microscope, histopathology, automated processing, lung disease, glioblastoma, Biobeat, patient monitoring, ulcerative colitis, pancreatic cancer, deep brain stimulation, Parkinson's Disease, macular degeneration, Angelman syndrome

Table of Contents

Global Advances in Life Sciences, Health & Wellness

  • Actorius Innovations & Research Pvt. Ltd.
  • Actorius Innovations & Research Pvt. Ltd.
  • Insilico Medicine
  • Insilico Medicine
  • Cochlear and GN Hearing
  • Cochlear and GN Hearing
  • Drawbridge Health
  • Drawbridge Health
  • Asceneuron
  • Asceneuron
  • Oxalys
  • Oxalys
  • Athira Pharma
  • Athira Pharma
  • Alector
  • Alector
  • ProMIS™ Neurosciences
  • ProMIS™ Neurosciences
  • Venari Medical
  • Venari Medical
  • Obsidio Inc.
  • Obsidio Inc.,
  • PATH EX Inc.,
  • PATH EX Inc.,
  • InnoSphere Ltd.
  • InnoSphere Ltd.
  • AbiliTech Medical Inc.
  • AbiliTech Medical Inc.,
  • CorInnova Inc.
  • CorInnova Inc.
  • ARTIDIS™ AG
  • ARTIDIS™ AG
  • inveox GmbH
  • inveox GmbH
  • Cambridge Respiratory Innovations Limited
  • Cambridge Respiratory Innovations Limited
  • Cedars-Sinai Hospital
  • Cedars-Sinai Hospital
  • Biobeat
  • Biobeat
  • InDex Pharmaceuticals
  • InDex Pharmaceuticals
  • AstraZeneca
  • AstraZeneca
  • Miracor Medical
  • Miracor Medical
  • Boston Scientific
  • Boston Scientific
  • Opthea
  • Opthea
  • GeneTx
  • GeneTx

Key Industry Contacts

  • Key Contacts
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Your F&S Thought Leader
Related Research
This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) captures insights across recent advances in life science, health & wellness. Key advances across liquid biopsy and cancer management have been included. The TOE also analyzes exciting device and therapeutic innovations for the management of neurodegenerative and cardiovascular disorders. Furthermore, the TOE examines recent advances across digital and artificial intelligence-based platforms for healthcare. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Liquid biopsy, cancer, artificial intelligence, drug design, digital health, cochlear, GN Hearing, hearing aid, Android Streaming, blood draw, HbA1C, neuromodulation, neurodegeneration, drug discovery, neuroscience, synapse, genomics, biomarkers, neuroscience, non-invasive therapy, venous disease, aneurysm, sepsis, ADHD, upper-limb neuromuscular disorder, CorInnova, heart failure, robotic, ARTIDIS, biopsy, microscope, histopathology, automated processing, lung disease, glioblastoma, Biobeat, patient monitoring, ulcerative colitis, pancreatic cancer, deep brain stimulation, Parkinson's Disease, macular degeneration, Angelman syndrome
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-0C-00-00
Is Prebook No
Ti Codes D759